Modeling the decision to undergo colorectal cancer screening: insights on patient preventive decision making

Medical Care
Sarah B WackerbarthSteven A Haist

Abstract

Little is known about how patients decide whether or not to undergo colorectal cancer screening. Although low screening rates evidence the outcome of these decisions, the processes patients use to balance benefits, risks, and costs with their own values and preferences are unclear. To increase screening rates, and ultimately save lives, it is important for providers to be aware of how patients make screening decisions. The purpose of this study was to identify patterns of patient colorectal cancer screening decisions that might be supported by health care providers. In this study, we focused on people from Central Kentucky--a region with historically low screening rates. We interviewed patients using a semi-structured format. Three members of the research team independently analyzed each interview transcript for factors that influenced the decision, and a pictorial representation of each decision process, based on Kurt Lewin's theory of decision making, was constructed for each participant. The individual decision processes were compared with identify patterns. Seventeen women and 13 men made up the sample. We discerned 7 decision patterns. This research documents 7 patterns and identifies common driving and restraining forces.

References

Nov 1, 1980·Annals of Internal Medicine·D S Brody
Jun 1, 1980·Annals of Internal Medicine·B R CassilethV March
Sep 28, 2000·Preventive Medicine·G A Brenes, E D Paskett
Jun 8, 2001·Preventive Medicine·E R WeitzmanK V Goins
Jul 3, 2003·Journal of Public Health Management and Practice : JPHMP·Donald A Cibula, Cynthia B Morrow
Nov 26, 2003·Preventive Medicine·Nancy K JanzKenneth E Guire
Feb 10, 2004·Preventive Medicine·K Allen GreinerEdward F Ellerbeck
Jul 1, 2004·Preventive Medicine·Parita PatelTushar Patel
Mar 12, 2005·Qualitative Health Research·Sarah B WackerbarthSteven A Haist
May 17, 2005·American Journal of Preventive Medicine·Catherine R MessinaRoger Grimson
May 27, 2005·Preventive Medicine·Christina C WeeRussell S Phillips
Aug 15, 2006·American Journal of Preventive Medicine·Jennifer Elston LafataL Keoki Williams
Sep 12, 2006·Cancer Detection and Prevention·Margalida GiliElena Cabeza

❮ Previous
Next ❯

Citations

Oct 6, 2011·Cancer Causes & Control : CCC·Maria Y HoWinson Y Cheung
Sep 9, 2008·Medical Care·Carrie N KlabundeMartin L Brown
Sep 9, 2008·Medical Care·Robert H Fletcher
May 20, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gladys N Honein-AbouHaidarNancy N Baxter
Jul 23, 2020·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Kia Teng LimChoon Seng Chong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved